Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement.

Keragala, Charithani B; Woodruff, Trent M; Liu, Zikou; Niego, Be'eri; Ho, Heidi; McQuilten, Zoe; Medcalf, Robert L

Keragala, Charithani B; Woodruff, Trent M; Liu, Zikou; Niego, Be'eri; Ho, Heidi; McQuilten, Zoe; Medcalf, Robert L.

Afiliação

Keragala CB; Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Woodruff TM; School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.
Liu Z; Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Niego B; Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Ho H; Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
McQuilten Z; Transfusion Research Unit, Department of Epidemiology and Preventative Medicine, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
Medcalf RL; Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.

Front Neurol ; 11: 577272, 2020.

Article em En | MEDLINE | ID: mdl-33363504

Palavras-chave

blood brain barrier; complement; fibrinolysis; plasminogen activation; tenecteplase; tissue-type plasminogen activator

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália